Form D · Pharmaceuticals
Havix Group, Inc
Hoschton, GA · CIK 0001650186
Offering snapshot reported Oct 25, 2017 · SEC filing
- Reported sold
- $600K Offering amount: $600K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500K Reported outside-investor minimum
- First sale
- Oct 20, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 25, 2017 | Initial | $600,000 | No comparison | 1 | SEC filing |
| Feb 14, 2017 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Aug 10, 2015 | Initial | $1,875,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-297348
No sales commissions of finders' fees were paid.
Source: Form D, filed Oct 25, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ashokkumar V Barot | Executive |
| Dhananjay Barot | Director, Executive |
| Ashok Barot | Director |
| Pankaj Chaudhari | Director |
| Gaurang Desai | Director |
| Ravi Patel | Director |
| Swapnil Shah | Director |
| Ameet Vyas | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
9488 Jackson Trail Road
Hoschton, GA, 30548
Hoschton, GA, 30548